DECK › analyze
DECK · Analyze
Price at analysis: $86.33 | 52wk range: $78.91–125.45 | Mkt cap: $11.76B | Sector: Consumer Cyclical / Footwear & Accessories
0. Knowledge Check
python .mcp/kb.py find DECK returned no matches — this is a first look, nothing to cite or contradict.
No live Themes/ sweep covers footwear/branded-apparel. The relevant Playbook entries that bear
directly on this name (applied throughout, not re-derived):
- [[pattern-buyback-manufactured-eps-screens-as-growth]] — fires on DECK's own Q1 FY27 print (see §1).
- [[pattern-incremental-margin-below-average-locks-in-decay]] — the identity used in §1 to separate the margin story from the narrative.
- [[pattern-margin-expansion-is-a-finite-growth-lever]] — relevant lens for judging whether the past EPS algorithm can repeat.
- [[principle-down-a-lot-is-not-cheap]] and its companion clause — used in §3 to check DECK's own historical band and the trajectory of the earnings denominator before crediting the drawdown as cheap.
- DECK is a US domestic filer (Goleta, CA) reporting in USD with a single share class — none of the ADR/FX/dual-class pitfalls apply. Checked and ruled out, not skipped.
1. Fundamentals
Multi-year trend (fiscal year ends March 31)
| FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|
| Revenue | $3.63B | $4.29B | $4.99B | $5.47B |
| Gross profit | $1.83B | $2.39B | $2.89B | $3.16B |
| Gross margin | 50.4% | 55.7% | 57.9% | 57.8% |
| Operating income | $652.8M | $927.5M | $1.18B | $1.26B |
| Operating margin | 18.0% | 21.6% | 23.6% | 23.1% |
| Net income | $516.8M | $759.6M | $966.1M | $1.02B |
| Diluted EPS | $3.23 | $4.86 | $6.33 | $7.02 |
| Diluted shares | 160.1M | 156.3M | 152.7M | 145.8M |
| OCF | $537.4M | $1.03B | $1.04B | $1.18B |
| FCF | $456.4M | $943.8M | $958.4M | $1.10B |
| Buybacks | $314.1M | $424.9M | $582.1M | $1.08B |
FCF CAGR (3yr, FY23→FY26): 34.0%. Revenue CAGR 14.7%, net income CAGR 25.6% — the gap between revenue and net-income growth is real margin expansion (18.0%→23.1% operating margin over four years), not manufactured. Through FY2026 this was a genuinely strong compounder.
Capital allocation of FY2026 FCF ($1.10B): buybacks absorbed $1.08B (98% of FCF) — essentially the entire free cash flow. No dividend, no debt paydown needed (net cash position), negligible M&A (goodwill flat at $14.0M for five years — organic growth only, no rollup risk). Share count fell 160.1M → 145.8M (FY23→FY26, −3.1%/yr), and the pace accelerated sharply into FY2027: diluted shares fell from 149.6M (Q1 FY26) to 138.6M (Q1 FY27) — a 7.4% single-year drop.
Debt/Assets: 10.2%. Total debt $375M against $1.9B cash — net cash of ~$1.5B. EBITDA/interest expense 529x (roic.ai). This is one of the cleanest balance sheets available in mid-cap consumer — leverage is a non-issue for this name.
⚠️ The quarter that moved the stock: Q1 FY2027 (June 2026), reported ~July 23, 2026
| Q1 FY26 | Q1 FY27 | Change | |
|---|---|---|---|
| Revenue | $964.5M | $1,019.5M | +5.7% |
| Operating income | $165.3M | $155.3M | −6.0% |
| Net income | $139.2M | $130.0M | −6.6% |
| Diluted shares | 149.6M | 138.6M | −7.4% |
| Diluted EPS | $0.93 | $0.94 | +1.1% |
This is a textbook instance of [[pattern-buyback-manufactured-eps-screens-as-growth]], happening in the agency's own portfolio-adjacent universe, not a hypothetical. Revenue grew, the business earned less (both op income and net income fell mid-single-digits), and EPS still rose a hair — purely because the share count fell faster than earnings did. A screener reading "EPS +1%, still positive" would miss that the underlying quarter was a genuine profit decline.
Applying [[pattern-incremental-margin-below-average-locks-in-decay]] to the same quarter: incremental operating margin = ΔOI / ΔRevenue = (−$9.99M) / (+$55.0M) = −18.2%. The marginal dollar of Q1 FY27 revenue was sold at a negative operating margin against a 15.2% quarterly average. That is not "average pulled down slowly" — it is the sharpest form of the identity: the incremental margin is below zero, so the operating-margin average is mechanically guaranteed to keep falling as long as this mix persists. Full-year roic.ai data shows the same erosion already underway before tariffs even bit: FY2026 incremental operating margin was 17.2%, down from 36.1% in FY2025 — well below the 23.1% FY2026 average even before the tariff step-up.
Named causes, not just arithmetic: management raised its go-forward tariff-rate assumption from 10% to 12.5%, adding a 150bp gross-margin drag versus the prior-year quarter that had no comparable tariff cost; continued reinvestment in international DTC buildout also pressured opex. This is a real cost headwind, not a one-quarter accounting artifact — tariffs at 12.5% are a standing tax on every future unit sold, not a lapping comparison that clears itself next quarter.
Per-share metrics
Revenue/share $37.53, FCF/share $7.53 (latest annual) — both rising steadily even through the FY2026 period, because the buyback pace has more than offset flat-to-declining aggregate profit growth. The buyback is real and funded (98% of FCF, no new debt) — this is not the debt-funded variant of the pattern — but it is doing real work to keep the per-share story intact while the aggregate-profit story decelerates.
Type-specific overlay
No dividend (payout ratio 0%) — DYT/DDM are N/A. Not a REIT/BDC. Standard growth/quality framework applies.
2. Moat & Competitive Advantage
ROIC: 34.4% (FY2026), 35.3% (FY2025) — high and only modestly declining (roic.ai
return_on_inv_capital). Gross margin: 57.7% (FY2026) vs 57.9% (FY2025) — essentially flat, not
compressing. Read together with §1: the moat's classic quantitative signals (ROIC, gross margin)
look intact; the erosion shows up one layer down, in operating leverage, not in the moat's usual
tells. This is a case where the standard moat test alone would under-read the risk — the incremental-
margin identity is the sharper instrument here.
Revenue-stream map: - HOKA (~47% of FY2026 revenue, $2.59B, +16% FY2026) — performance running, differentiated cushioning/geometry, strong reviews and repeat-purchase behavior, still taking share from Nike alongside On Holding (HOKA + On ≈19% combined US premium-running share in 2026). This is the brand decelerating fastest: FY2026 full-year +16%, Q4 FY26 +14.5%, Q1 FY27 down to +7.7% — a halving of growth rate in two quarters. - UGG (~45-48% of revenue) — iconic but fashion-cyclical lifestyle/boot brand with a documented history of multi-year down-cycles (2015–2018). Had its own DTC-slowdown scare in Q2 FY26 (Oct 2025, stock −15% same day) on "hitting a wall" concerns, then beat again in the holiday Q3 FY26 print with UGG +5%. This is now the second growth-scare cycle on the same two brands within twelve months — each time partially reversing the next quarter, which cuts both ways: it argues the market over-reacts to single quarters, and it argues the deceleration is a recurring, real signal rather than one-off noise. - Teva / Koolaburra / Ahnu — immaterial, niche.
Adversarial stress-test: "You are a well-funded rival — how easily do you attack this?" Nike is larger but structurally challenged (TTM revenue −9.8%, net income −43.5% per recent filings) and is fighting its own turnaround rather than pressing an attack. On Holding is the more dangerous rival — faster-growing, premium-positioned, and directly overlapping HOKA's running category; the combined HOKA+On share gain against Nike shows the running category itself is contestable and up for grabs between two well-funded challengers, not a HOKA-only moat. UGG faces lower-cost sheepskin-boot imitators structurally, but brand and DTC control have held the premium tier for over a decade. Verdict: a real brand moat exists (repeat purchase, DTC margin capture, no debt-funded rollup risk), but it is a two-brand portfolio moat, not a fortress — the category leadership in running is shared, not owned, and UGG's engine is cyclical by nature.
Disruption forecast (5–10yr): Near-term (1–2yr) risk is category maturation, not disintermediation — HOKA's running-shoe TAM growth naturally slows as its own base scales (law of large numbers effect on the +16%→+7.7% print), and UGG's boot category is inherently seasonal/fashion- driven. Medium-term (3–5yr) risk is On Holding and a resurgent Nike compressing HOKA's premium pricing power. Long-term risk is negligible existential disruption — footwear brand equity is durable — but growth-rate compression from "teens" to "high-single-digits" as both brands mature is the base case, not a tail risk.
Evergreen assessment: Not a forever-growth business at the current rate; more likely a durable, cash-generative brand house that settles into mid-to-high-single-digit organic growth once both brands mature, funded by continued heavy buybacks. That is a fine business — it is a different multiple than the 25–30x the market paid for it in 2023–2024 when both brands were compounding at teens-to-20%+.
3. Valuation
Applied conditionally: no dividend, so DYT/DDM are N/A. Graham weighted low (asset-light brand business, book value structurally depressed by the buyback, not representative of earning power). FCF-multiple and Bogle-style forward-return framing carry the weight, consistent with the framework's guidance for non-dividend, still-growing names.
| Model | Inputs | Output |
|---|---|---|
| Graham IV | EPS(ttm) $6.79, BVPS $16.83 | √(22.5×6.79×16.83) = $50.71 — well below price. Flagged, not weighted: BVPS is compressed by $1.08B of buybacks against a high-ROE (34% ROIC), asset-light brand model; Graham systematically understates fair value for this shape of company (small book, large earning power) and is included only for completeness. |
| Forward P/E, current-year corrected | epsCurrentYear $7.54 / priceEpsCurrentYear 11.46x (Yahoo's raw forwardPE 10.32x prices forwardEps $8.36, a further-out estimate — cross-checked per [[pitfall-vendor-forward-eps-is-the-wrong-fiscal-year]]). Company's own FY27 guide: EPS $7.35–7.50, consistent with the corrected current-year figure. |
At the current price, DECK trades 11.5x current-FY EPS |
| Own-history band | FY2023–24 (teens-to-20%+ brand growth phase): stock traded $150–220 against EPS then in the $5–6 range → ~28–33x. Current 11.5x is under half that band. | Genuine multiple compression, not merely a price drawdown — passes [[principle-down-a-lot-is-not-cheap]]'s stricter test because the earnings base is still growing (not reset/shrinking), even though the growth rate has fallen. |
| Bogle expected return | No dividend component. Earnings growth ~5-9%/yr near-term (company FY27 guide implies ~5-8% EPS growth off TTM, buyback-assisted) plus optional multiple normalization if deceleration stabilizes. Conservative case (no re-rating): high-single-digit total return from earnings growth and buybacks alone. Bull case (partial re-rating to 16-18x): 25-45% over 12-24 months. State the assumption plainly: this return case leans on the multiple, not just the business, and multiple recovery is not guaranteed on the current print. |
Fair value range: $95–130. Built off the corrected current-year EPS (~$7.40 mid-guide) at a 13x–18x band: 13x is the level Jefferies flagged as "HOKA slowdown fully priced in" ($96), 18x is a moderate premium reflecting the intact ROIC/balance sheet but well short of the 28-33x the market paid during the high-growth phase ($133). Analyst consensus sits inside this range but toward the top (target mean $122.81, target low $85 — notably the street's own bear case is barely below the current price, target high $184).
Entry zone: $80–95 — current price ($86.33) is already inside it, near the low end of the fair-value range and just above the 52wk low ($78.91).
Trim: 22x fwd (not a fixed dollar — per framework convention, this rises with the corrected current-year EPS as it's reported). 22x is a deliberate re-rating ceiling below the 28-33x historical peak — it assumes partial, not full, multiple recovery, consistent with a maturing (not reversing) growth story.
4. Sentiment — why is it near its 52-week low right now
Three growth-scare cycles on the same two brands inside twelve months:
- Oct 2025 (Q2 FY26 print): stock fell −15% on UGG DTC deterioration — management cited improved wholesale in-stocks (i.e., channel normalization pulling share from DTC), softer consumer sentiment, and a shift to multi-brand shopping. Needham's Tom Nikic warned the brands "may be hitting a wall."
- Jan/Feb 2026 (Q3 FY26, holiday print): both HOKA and UGG beat, UGG posted record quarterly revenue (+5%), stock rallied hard (price recovered from the Nov 2025 low of $78.91 to $102–122 through Q1 2026) — the naysayers were "quieted." Jefferies upgraded to Buy on the view that the HOKA slowdown was "fully priced in at 13x earnings."
- Late July 2026 (Q1 FY27): revenue and EPS both beat consensus, full-year guidance was raised — and the stock still fell −6% same-day, then continued sliding through August to the current $86.33. The market's read: HOKA growth halved (16%→7.7%), net income fell −6.6%, and management raised the tariff assumption to 12.5% — a structural cost, not a comp effect. The market is not reacting to the headline miss/beat at all — it is reacting to the incremental-margin deterioration and the deceleration rate, exactly the two things §1–2 quantify.
Insider signal: neutral-to-mildly-cautious, not a clean buy signal. No open-market insider purchases at the current depressed price (~$86) — the one buy on record in the last 18 months was a director's $200K purchase at $109.76 in June 2025, well above today's price. Recent insider activity is dominated by routine RSU vesting (grants at $0.00) and small, likely 10b5-1-scheduled sales by officers/directors at much higher historical prices ($104–208 through 2024–2026) — nothing resembling insider conviction at the current level. Absence of buying at a 52-week low is not damning on its own (earnings-window blackout considerations apply, last report was Aug 17, 2026), but it means the "insiders are backing up the truck" signal — often present in genuine value dislocations — is not available here as corroboration.
Institutional positioning: top holders (BlackRock 9.9%, Vanguard entities combined ~11%, State
Street 4.6%) show a mixed but mostly negative pctChange in the most recent 13F window (BlackRock
−8.5%, FMR −13.8%, AQR −30.7%), with a few adding (State Street +2.2%, Geode +6.2%, Morgan Stanley
+15.4%). Net reads as distribution exceeding accumulation among the largest holders — consistent
with a stock still being sold into, not yet a base-building phase.
Analyst consensus: "Buy" average rating (2.35/5, i.e., buy-leaning), 21 analysts, mean target $122.81 (+42% from here), but target low is $85 — essentially at the current price, meaning even the street's most conservative published target sees limited further downside.
Sentiment/cyclical vs. structural verdict: Mixed, weighted toward cyclical-with-a-real-kernel. The recurring pattern (crash on deceleration fear → beat-and-rally → crash again) argues for overreaction each time it happens; but the specific mechanism this time — a tariff-rate increase that does not lap away, plus a genuine, quantified (not narrative) negative incremental operating margin — is a real cost structure change, not merely sentiment. This is not a value trap (ROIC intact, balance sheet pristine, both brands still growing revenue), but it is also not a pure sentiment overreaction with no fundamental basis — the margin compression is real and current, even if the growth-rate deceleration has partially reversed twice before.
5. Synthesis — Weighted Verdict
Weighting rationale: DECK is a still-growing, non-dividend consumer brand compounder — per the framework, Moat + Sentiment should carry more weight than a static Graham valuation for this company type, but the magnitude of the current de-rating (11.5x vs a 28-33x own-history band) is large enough that Fundamentals/Valuation earn equal weight this cycle — the multiple compression is doing as much work in the thesis as the qualitative brand story.
Tension to name explicitly: Fundamentals/Moat data (ROIC 34%, gross margin flat at 57.7%, net cash balance sheet, revenue still growing) argue this is quality on sale. Sentiment/the incremental- margin identity argue the market is pricing a real, currently-measurable deterioration (negative Q1 incremental operating margin, tariff step-up, HOKA growth rate cut in half) — not merely reacting to noise. Both are true simultaneously; the verdict has to hold both, not average them into false comfort.
Verdict: ACCUMULATE, conviction 6.5/10. The balance sheet, ROIC, and own-history multiple band support building a position into the current weakness — analyst target-low ($85) and this analysis's entry zone ($80-95) both sit near the current price, which limits (does not eliminate) further downside without a fresh negative catalyst. This falls short of a high-conviction BUY because the margin deterioration is current and quantified, not merely feared, and because insider buying — the strongest corroborating signal available when a name sits at a 52-week low — is absent at this price. Size as an add into strength-through-weakness, not a single full-size entry, and treat the next print (Q2 FY27, ~late October 2026, the holiday-quarter guide) as the real test: a HOKA growth rate that stabilizes in the high-single-digits rather than continuing to decelerate, and an incremental operating margin that turns positive again, would upgrade this; a further slide in either would argue the "cyclical" read was wrong and this was structural after all.
Key risks (named, not buried)
- Tariff-rate assumption (12.5%) is a standing cost, not a lapping comparison — it will continue to pressure gross margin every quarter until it is negotiated away or absorbed by price increases the brand can or cannot sustain.
- HOKA deceleration (16%→7.7% in two quarters) could reflect either normal law-of-large-numbers maturation (survivable, priced-in) or the beginning of a real share loss to On Holding (not yet distinguishable from one data point — watch the next print closely).
- No insider buying at the current price removes a corroborating signal this analysis would otherwise lean on.
- UGG's structural fashion-cyclicality — the brand has had multi-year down-cycles before (2015– 2018); a repeat is a real tail risk this analysis cannot rule out from financials alone.
Sources: .mcp/fin.py DECK --news, Yahoo Finance MCP (get_stock_info, quarterly income_stmt,
insider_transactions, institutional_holders, historical prices), roic.ai MCP
(get_profitability_ratios, get_credit_ratios — NYSE:DECK), WebSearch (Zacks, GuruFocus,
TradingView/Zacks, SGI Europe, WWD, CNBC, Yahoo Finance, BigGo Finance — see inline citations above).